Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02011542 · ClinicalTrials.gov registry record · Phase 2
Probiotic (VSL #3) for Gulf War Illness
A Phase 2 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT02011542 is a Phase 2 study that was terminated before completion, run by University of Utah. The registered enrollment target is 29 participants.
The verdict
NCT02011542, a Phase 2 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
The overall objective is to determine whether VSL #3 will improve 1) intestinal symptoms of Irritable Bowel Syndrome (IBS) and 2) non-intestinal symptoms (fatigue, joint pain, insomnia, general stiffness and headache) associated with IBS. All of these symptoms are part of the Gulf War (GW) illness.
Interventions
- DRUG Placebo
- DRUG VSL#3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02011542
The ClinicalTrials.gov registry entry for NCT02011542 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02011542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02011542 about?
NCT02011542 is a clinical study titled "Probiotic (VSL #3) for Gulf War Illness". The overall objective is to determine whether VSL #3 will improve 1) intestinal symptoms of Irritable Bowel Syndrome (IBS) and 2) non-intestinal symptoms (fatigue, joint pain, insomnia, general stiffness and headache) associated with IBS. All of these symptoms are part of the Gulf War (GW) illness.
What is the current status of trial NCT02011542?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2013-09. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02011542?
The interventions under investigation include: Placebo (DRUG), VSL#3 (DRUG).
Who is sponsoring clinical trial NCT02011542?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.